We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Clears Cepheid Xpert CT/NG Molecular Diagnostic Test
FDA Clears Cepheid Xpert CT/NG Molecular Diagnostic Test
January 1, 2013
Cepheid announced it has received clearance from the FDA to market Xpert CT/NG. Running on Cepheid’s GeneXpert Systems, Xpert CT/NG is a qualitative in vitro molecular diagnostic test for the detection and differentiation of Chlamydia trachomatis and Neisseria gonorrhoeae. News Medical
